


New York State Genetics Task Force


From no genetic testing in the 90s to identifying variants across 110+ genes linked to Leigh syndrome today. Today's story traced the impact of genomic progress on families living with rare disease. #genetics #RareDisease

"Every patient has a story. Let them tell it." A powerful reminder that behind every genetic result is a family navigating uncertainty, grief, and hope; and that our communication matters as much as our science. #GeneticCounseling #genechat

Lastly, we will hear from a patient advocate in the talk “A Silver Lining: A parent’s perspective on how far we’ve come and your impact”

OGM sits right at the intersection of our tools: Karyotype: broad overview, low resolution FISH: highly sensitive, but targeted CMA: great for CNVs, but misses balanced events OGM can capture aneuploidies, CNVs, translocations, inversions, and rearrangements in one assay.

Really interesting session on optical genome mapping (OGM) as next‑gen cytogenetics. It offers a genome‑wide view like karyotype, but with resolution closer to (and beyond) microarray, and it can detect balanced structural variants that arrays miss. #Cytogenetics #OGM

Next we will here from Dr. Anwar Iqbal on how Optical Genome Mapping enables Next-Generation Cytogenetics

From ‘no diagnosis’ to clear answers: episignature testing is helping resolve tough cases with: -Undiagnosed neurodevelopmental disorders -Suspected imprinting conditions -Overgrowth/undergrowth syndromes #RareDisease

Key takeaways from the episignature talk: -Over 100 conditions now have recognizable epigenetic -signatures -Especially powerful for interpreting VUS in genes that regulate methylation -Not a replacement for exome or genome #Episignature #Epigenetics

Next we will here from Lexi Hubbel, MS, CGC on Methylation Episignature Testing: A diagnostic tool for VUS resolution and undiagnosed rare disease

For families facing early‑onset retinal disease the message from Dr. Levin’s work is hopeful: Open‑access vectors Not‑for‑profit pricing International training & delivery If it succeeds, this model could reshape how genetic eye diseases are treated worldwide.

There however are political, financial, and sociological barriers that keep this from being available to everyone that it could potentially be helpful for.

From congenital blindness to catching frisbees: Dr. Levin shared how RPE65 gene therapy transformed vision in children with Leber congenital amaurosis. When viable retinal cells remain, gene therapy can restore meaningful function within weeks. #GeneTherapy #Ophthalmology

First up we have Dr. Alex Levin from @FlaumEye Institute at the University of Rochester who will speak about Ocular gene therapy: opportunities, successes, and challenges

Good morning! We are just getting started. Still time to join our September meeting! We have a bunch of great speakers today. Here is the link to register: us06web.zoom.us/meeting/regi…

Join us Sept 9 for the next NYSGTF meeting: Genetics Updates in the Clinic and Beyond 🗓️ 9/9/26 | 9:00am 📍 In-person @UR_Med, Rochester, NY + virtual option Register: us06web.zoom.us/meeting/regi… Agenda below ⬇️ #genetics #NYSGTF #genechat